https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-08-01 / Hematol. Oncol. Clin. North Am. 2006 Aug;20(4):965-83, xi
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-08-01 / Hematol. Oncol. Clin. North Am. 2006 Aug;20(4):965-83, xi2006-08-01 00:00:002019-02-15 09:24:15Immunotherapy for prostate cancer: what’s the future?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-08-01 / J. Virol. 2006 Aug;80(15):7522-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-08-01 / J. Virol. 2006 Aug;80(15):7522-342006-08-01 00:00:002019-02-15 09:22:12Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-15 / Int. J. Cancer 2006 Jul;119(2):328-38
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-15 / Int. J. Cancer 2006 Jul;119(2):328-382006-07-15 00:00:002020-06-23 09:36:30Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-13 / Immunobiology 2006;211(6-8):677-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-13 / Immunobiology 2006;211(6-8):677-852006-07-13 00:00:002019-02-15 08:32:39Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-502006-07-01 00:00:002019-02-15 09:00:00Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-312006-07-01 00:00:002019-02-15 09:00:01Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-92006-07-01 00:00:002006-07-01 00:00:00The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-30 / Cell. Immunol. 2006 Feb;239(2):144-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-30 / Cell. Immunol. 2006 Feb;239(2):144-502006-06-30 00:00:002019-02-15 09:11:48Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-832006-06-13 00:00:002019-02-15 09:23:48Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-01 / Cell. Mol. Immunol. 2006 Jun;3(3):197-203
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-01 / Cell. Mol. Immunol. 2006 Jun;3(3):197-2032006-06-01 00:00:002019-02-15 09:03:06Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma
